Enhance the translatability of the immune/efficacy-related effects of biologics using one humanized mouse model

Content

‍

▶️ genO-BRGSF-HIS mice recapitulate key CRS features induced by biologics tested in the clinic

‍

▶️ Immune cells are recruited, polarized and activated in the tumor microenvironment in genO-BRGSF-HIS mice

‍

▶️ genO-BRGSF-HIS enables the assessment of both efficacy and safety in a single model

‍

‍

Speaker

‍

Fabiane Sônego, PhD in Immunology and Pharmacology, is the Director of Preclinical Models and Services at genOway. She has extensive expertise in in vivo models for immuno-oncology and inflammation and a proven track record of supporting researchers in advancing translational research and accelerating drug development.

‍